Skip to main content
. 2022 Jan 26;13:817526. doi: 10.3389/fphar.2022.817526

FIGURE 3.

FIGURE 3

Punicalagin attenuates the enhancement of IL-1β by suppressing NF-κB activation and caspase-1 expression in vivo. (A) The relative mRNA level of IL-1β in Control/IMQ/IMQ + DEX/IMQ + Vehicle/IMQ + PUN groups. (B) The protein expression of IL-1β in Control/IMQ/IMQ + DEX/IMQ + Vehicle/IMQ + PUN groups. (C, D) Immunohistochemical staining and statistical analysis of phosphorylated p65 (Ser536) in skin sections derived from the Control/IMQ/IMQ + DEX/IMQ + Vehicle/IMQ + PUN group. Scale bars: 200 μm. (E) The expression of cleaved and total caspase-1 in skin sections derived from the Control/IMQ/IMQ + DEX/IMQ + Vehicle/IMQ + PUN group. (F) The relative mRNA level of CXCL-1 (left) and CCL-20 (right) in the skin lesions from Control/IMQ/IMQ + DEX/IMQ + Vehicle/IMQ + PUN groups. *p < 0.05, ***p < 0.001, N.S., non-significant. One-way ANOVA with Student-Newman-Keuls method for (A, D, F). Data represent the mean ± S.E.M.